Champions Oncology Inc
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Show More...
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 5.87 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-04 2011-04 2012-04 2013-04 2014-04 2015-04 2016-04 2017-04 2018-04 2019-04 TTM Earnings Per Share USD -1.08 -1.32 -2.28 -1.44 -2.16 -2.2 -1.2 -0.64 -0.13 0.010 -0.010 Dividends USD Payout Ratio % * Shares Mil 3.0 3.0 4.0 4.0 6.0 6.0 9.0 11.0 11.0 14.0 14.0 Book Value Per Share * USD 0.78 -1.83 3.14 0.8 -0.48 0.26 0.19 0.04 0.2 0.26 Free Cash Flow Per Share * USD 0.48 -1.47 -1.23 -0.88 -1.37 -0.92 -0.43 -0.22 0.05 Return on Assets % -68.36 -45.86 -88.5 -68.16 -72.19 -125.66 -117.21 -99.85 -18.35 1.32 -1.39 Financial Leverage (Average) 2.49 665.79 1.52 2.77 1.49 24.27 20.03 2692.67 5.03 4.75 Return on Equity % -167.36 -476.44 -527.94 -136.23 -233.48 -251.8 -732.51 11.42 -6.58 Return on Invested Capital % -167.65 -476.44 -527.94 -136.23 -233.48 -251.8 -732.51 11.26 -3.74 Interest Coverage Current Ratio 1.51 3.38 1.59 3.54 2.08 2.84 0.82 0.79 0.68 0.99 0.96 Quick Ratio 1.25 3.3 1.53 3.44 1.97 2.74 0.73 0.75 0.64 0.95 0.92 Debt/Equity 1.03